The Journal of Heart and Lung Transplantation
Volume 28, Issue 7 , Pages 667-669 , July 2009

Heart Transplantation in Human Immunodeficiency Virus–Positive Patients

  • Nir Uriel, MD

      Affiliations

    • Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, New York
  • ,
  • Ulrich P. Jorde, MD

      Affiliations

    • Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, New York
  • ,
  • Vlad Cotarlan, MD

      Affiliations

    • Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, New York
  • ,
  • Paolo C. Colombo, MD

      Affiliations

    • Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, New York
  • ,
  • Maryjane Farr, MD

      Affiliations

    • Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, New York
  • ,
  • Susan W. Restaino, MD

      Affiliations

    • Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, New York
  • ,
  • Katherine Lietz, MD

      Affiliations

    • Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, New York
  • ,
  • Yoshifuma Naka, MD, PhD

      Affiliations

    • Division of Cardiothoracic Surgery, College of Physicians and Surgeons, Columbia University, New York, New York
  • ,
  • Mario C. Deng, MD

      Affiliations

    • Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, New York
  • ,
  • Donna Mancini, MD

      Affiliations

    • Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, New York
    • Corresponding Author InformationReprint requests: Donna Mancini, MD, 622 W 168 St, New York, NY 10032. Telephone: 212-305-4629. Fax: 212-305-2591

Received 26 November 2008 ,Revised 17 March 2009 ,Accepted 7 April 2009.

References 

  1. Porter K, Babiker A, Bhaskaran K, et al. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet. 2003;362:1267–1274
  2. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397–406
  3. Calabrese LH, Albrecht M, Young J, et al. Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med. 2003;348:2323–2328
  4. Gupta S, Markham DW, Mammen PP, et al. Long-term follow-up of a heart transplant recipient with documented seroconversion to HIV-positive status 1 year after transplant. Am J Transplant. 2008;8:893–896
  5. Barbarinia G, Barbaro G. Incidence of the involvement of the cardiovascular system in HIV infection. Aids. 2003;17(suppl 1):S46–S50
  6. Jahangiri B, Haddad H. Cardiac transplantation in HIV-positive patients: are we there yet?. J Heart Lung Transplant. 2007;26:103–107
  7. Bisleri G, Morgan JA, Deng MC, Mancini DM, Oz MC. Should HIV-positive recipients undergo heart transplantation?. J Thorac Cardiovasc Surg. 2003;126:1639–1640
  8. Ciuffreda D, Pantaleo G, Pascual M. Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation. Transpl Int. 2007;20:649–658

PII: S1053-2498(09)00227-7

doi: 10.1016/j.healun.2009.04.005

The Journal of Heart and Lung Transplantation
Volume 28, Issue 7 , Pages 667-669 , July 2009